Titan Pharmaceuticals Q3 EPS $(0.18) Beats $(0.21) Estimate, Sales $947K Beat $700K Estimate

Titan Pharmaceuticals (NASDAQ:TTNP) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 63.64 percent decrease over losses of $(0.11) per share

Benzinga · 11/14/2019 21:16

Titan Pharmaceuticals (NASDAQ:TTNP) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 63.64 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $947 thousand which beat the analyst consensus estimate of $700 thousand by 35.29 percent. This is a 42.61 percent decrease over sales of $1.65 million the same period last year.